Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$871,024,939
-$9,026,633 QoQ
Shares Held
726,199
-24.1% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $2,791,248,361 across 11 Drug Manufacturers - General names. LLY ranks #1 (31.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
726,199 | $871,024,939 | |
| 2 | JNJ |
Johnson & Johnson
|
2,566,595 | $651,838,132 | |
| 3 | ABBV |
AbbVie Inc.
|
1,598,568 | $402,263,651 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,030,023 | $260,857,955 | |
| 5 | AMGN |
Amgen Inc
|
471,833 | $170,860,165 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,071,977 | $135,433,574 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,716,000 | $98,875,920 | |
| 8 | PFE |
Pfizer Inc
|
3,801,302 | $91,535,352 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $871,024,939 | 726,199 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $880,051,572 | 956,817 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $894,447,649 | 832,292 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $615,638,758 | 806,866 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $656,216,149 | 841,810 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $612,595,617 | 741,722 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $565,528,600 | 732,550 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $734,782,689 | 829,382 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $749,365,823 | 827,681 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $644,991,076 | 829,080 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $538,785,960 | 924,288 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $514,640,366 | 958,130 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $438,693,271 | 935,420 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $408,049,240 | 1,188,193 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $359,123,909 | 981,642 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $290,651,877 | 898,877 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $362,057,265 | 1,116,668 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $281,432,408 | 982,758 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $278,362,914 | 1,007,758 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $271,984,204 | 1,177,166 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $186,261,447 | 811,526 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $164,464,745 | 880,338 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $67,173,162 | 397,851 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $49,416,625 | 333,851 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $34,913,041 | 212,651 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $120,416,034 | 868,051 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||